Salicylic Acid (DB00936): A Comprehensive Monograph on its Chemistry, Pharmacology, and Clinical Utility

Executive Summary

Salicylic acid (DrugBank ID: DB00936) is a beta-hydroxy acid that occupies a unique and enduring position in the therapeutic landscape, functioning as both a widely accessible over-the-counter (OTC) agent and a potent prescription medication. Its primary mechanism of action in dermatology is as a desmolytic and keratolytic agent, enabling it to effectively remove the outer layer of the stratum corneum.[1] This core function underpins its broad spectrum of clinical applications, which range from the management of acne vulgaris and dandruff to the treatment of more severe hyperkeratotic disorders such as psoriasis, ichthyosis, and warts.[1] The therapeutic and toxicological profile of salicylic acid is critically dependent on its concentration, which dictates its function from a gentle exfoliant to a potent tissue-destructive agent. Consequently, appropriate formulation selection and comprehensive patient counseling are paramount to maximizing its clinical efficacy while mitigating the significant risks of local skin irritation and, in cases of excessive use or improper application, systemic toxicity (salicylism).[5]

Section 1: Identification and Physicochemical Profile

This section establishes the fundamental chemical identity of salicylic acid, providing a comprehensive reference for its properties. This foundational data is crucial for understanding its formulation, stability, and pharmacokinetic behavior.

1.1. Nomenclature and Chemical Identifiers

• Primary Name: Salicylic acid [1]
• Systematic (IUPAC) Name: 2-hydroxybenzoic acid [7]
• Common Synonyms: o-Hydroxybenzoic acid, 2-Carboxyphenol, Acidum salicylicum [7]
• Database Identifiers:
• DrugBank ID: DB00936 [1]
• CAS Number: 69-72-7 [8]
• PubChem CID: 338 [1]
• EC Number: 200-712-3 [8]
• UNII: O414PZ4LPZ [1]
• ATC Codes: D01AE12 (Topical antifungals), N02BA04, N02BA12 (Analgesics), S01BC08 (Ophthalmologicals) [11]

The assignment of multiple Anatomical Therapeutic Chemical (ATC) classification codes to salicylic acid reveals its extensive and often overlooked therapeutic history beyond dermatology.[11] While this monograph focuses on its topical applications, the codes for nervous system analgesics and ophthalmological use allude to a broader systemic pharmacology, primarily through its role as the active metabolite of aspirin.[14] This systemic activity is the basis for the risk of salicylism when significant percutaneous absorption occurs, directly linking the drug's classification to its systemic safety profile.

1.2. Chemical Structure and Properties

• Molecular Formula: C7​H6​O3​ [1]
• Hill Formula: C7​H6​O3​ [8]
• Molecular Weight: 138.122 g/mol [1]
• Chemical Representations:
• SMILES: c1ccc(c(c1)C(=O)O)O [1]
• InChI Key: YGSDEFSMJLZEOE-UHFFFAOYSA-N [1]
• Structural Description: Salicylic acid is an aromatic hydroxy acid composed of a benzene ring substituted with a hydroxyl group (−OH) and a carboxyl group (−COOH) at ortho positions to each other.[16] This specific chemical architecture is the direct source of its dual functionality. The carboxyl group provides the acidity necessary for disrupting the intercellular cement between keratinocytes, while the hydroxyl group and benzene ring confer a lipophilic character.[17] This lipophilicity is crucial, as it allows the molecule to penetrate the lipid-rich environment of the stratum corneum and sebaceous follicles, explaining its unique efficacy as a comedolytic agent in acne compared to more water-soluble alpha-hydroxy acids (AHAs).

1.3. Physical and Organoleptic Properties

Salicylic acid presents as a colorless to white, odorless crystalline powder or solid.[14] Some preparations may have a faint nutty or phenolic odor and a sweetish, acrid taste.[13] Its physical properties are summarized in Table 1. The low aqueous solubility explains the prevalence of alcohol-, gel-, or ointment-based formulations designed to effectively deliver the drug to the skin. The pKa of approximately 3.0 is a critical determinant of its acidic nature and keratolytic activity, as its biological effect is highly pH-dependent.[2]

Table 1: Physicochemical Properties of Salicylic Acid

Property	Value	Source(s)
Appearance	Colorless to white crystalline powder	14
Molecular Formula	C7​H6​O3​	1
Molecular Weight	138.122 g/mol	1
Melting Point	158–161 °C	13
Boiling Point	211 °C	8
Sublimation Temperature	76 °C	14
Density	1.443 g/cm³ (at 20 °C)	8
Solubility in Water	1.8 g/L (at 20 °C)	22
Solubility in Ethanol	Soluble (e.g., 1 M at 20 °C)	13
pKa	2.98–3.0	21
Vapor Pressure	1 mmHg (at 114 °C)	13
Flash Point	157 °C	8
Autoignition Temperature	500–570 °C	8

Section 2: Historical Development from Willow Bark to Modern Pharmacopoeia

The evolution of salicylic acid from an ancient herbal remedy to a cornerstone of modern pharmacology provides essential context for its enduring relevance. This history illuminates the scientific journey that refined its use and ultimately led to the development of safer, systemically administered derivatives like aspirin.

2.1. Ancient and Traditional Use

The medicinal use of salicylate-containing plants, most notably the bark of the willow tree (genus Salix), dates back millennia as a treatment for pain, fever, and inflammation.[14] The earliest known records are approximately 4,000-year-old Sumerian clay tablets that describe the pain-relieving properties of the willow tree.[15] Ancient civilizations, including the Egyptians, Assyrians, Chinese, and Greeks, also employed willow bark for its therapeutic effects.[24] The Greek physician Hippocrates (c. 400 BCE) is famously credited with recommending that patients chew willow bark to alleviate pain and fever and use a willow-brewed tea to ease the pain of childbirth.[15] However, some historical analyses suggest this specific attribution may be a modern myth, as the willow species available to Hippocrates may have contained insufficient concentrations of the active compound, salicin, to be clinically effective.[1] The name "salicylic" itself is a direct homage to this history, derived from the Latin word for willow,

salix.[14]

2.2. Scientific Isolation and Synthesis

The transition from herbal remedy to purified chemical began in the 18th and 19th centuries. In 1763, the English clergyman Reverend Edward Stone published the first formal clinical trial, documenting the efficacy of dried willow bark powder in treating feverish conditions known as "agues".[15] This spurred further chemical investigation. In 1828, Professor Johann Büchner of Munich successfully isolated a bitter-tasting, yellow, crystalline substance from willow bark, which he named "salicin".[15] This was followed in 1829 by the isolation of a purer form by the French pharmacist Henri Leroux.[15]

A pivotal breakthrough occurred in 1838 when the Italian chemist Raffaele Piria transformed salicin into a more potent acidic compound, which he named salicylic acid.[28] By the mid-19th century, the chemical structure of salicylic acid had been identified, and German chemists, including Hermann Kolbe, developed a method for its synthetic production.[15] This innovation enabled the first commercial mass production by the Heyden Chemical Company, making the drug widely available for medical use.[15] By 1876, German physicians were publishing the first clinical reports on the successful use of synthetic salicylic acid for treating rheumatic disorders.[29]

2.3. The Genesis of Aspirin and the Evolution of Salicylate Therapy

Despite its effectiveness, the widespread use of salicylic acid was hampered by a significant drawback: severe gastrointestinal irritation, which frequently caused nausea, vomiting, and bleeding, making long-term therapy intolerable for many patients.[24] This critical clinical problem drove the search for a better-tolerated alternative. The development of aspirin was not the invention of a new drug class but rather a deliberate refinement of an existing one to mitigate this known toxicity.

In 1853, Charles Gerhardt first synthesized acetylsalicylic acid (ASA), but his preparation was impure and unstable.[25] The definitive synthesis was achieved in 1897 by Felix Hoffmann, a chemist at the German company Bayer. Motivated by his father's inability to tolerate salicylic acid for arthritis, Hoffmann developed a method to produce a pure and stable form of ASA through the acetylation of salicylic acid's hydroxyl group.[24] This new compound was registered by Bayer in 1899 under the trade name "Aspirin".[24]

This history represents a classic pharmacological paradigm: the progression from a crude natural product (willow bark) to a purified active principle (salicylic acid) and finally to a synthetically optimized prodrug (aspirin) designed to improve tolerability. Salicylic acid occupies the crucial midpoint in this evolution—more potent and standardized than the original bark, but less tolerated systemically than its acetylated derivative. Its modern therapeutic niche as a primarily topical agent leverages its high local efficacy while strategically minimizing the systemic exposure that historically proved so problematic.

Section 3: In-Depth Pharmacological Analysis

This section provides a detailed examination of how salicylic acid functions at a molecular and physiological level, bridging the gap between its chemical properties and its observed clinical effects.

3.1. Mechanism of Action

Salicylic acid exerts its therapeutic effects through a complex, multi-modal mechanism of action, which accounts for its utility across a diverse range of dermatological disorders.[17]

3.1.1. Keratolytic and Desmolytic Effects

The primary and most recognized action of topical salicylic acid is its ability to remove the outermost layer of the skin, the stratum corneum.[1] Historically termed a keratolytic, its mechanism is now understood with greater nuance. Rather than lysing or breaking down the keratin protein filaments within cells, salicylic acid functions primarily as a

desmolytic agent.[2] It achieves this by dissolving the intercellular cement substance that binds corneocytes together and disrupting the cellular junctions, or desmosomes, that anchor these cells to one another.[2] This action weakens cell-to-cell adhesion, causing the cells of the epidermis to shed more readily in a process known as desquamation.[1] It also increases endogenous hydration within the stratum corneum, which causes this horny layer to swell, soften, and subsequently desquamate.[32] This desmolytic action is elegant and targeted, explaining its efficacy at lower, non-destructive concentrations in treating conditions of cellular retention like acne. At higher concentrations, this effect becomes more aggressive and caustic, leading to true keratolysis and tissue destruction, which is harnessed for the removal of warts.[32]

3.1.2. Comedolytic Properties

A key feature distinguishing salicylic acid in the treatment of acne vulgaris is its comedolytic activity. Its lipophilic structure allows it to effectively penetrate the lipid-rich environment of the pilosebaceous unit.[17] Once inside the follicle, it exfoliates the pore lining, helping to unclog blocked pores and break down existing comedones (both open and closed).[1] This prevents the accumulation of sebum and keratin debris that leads to the formation of acne lesions.

3.1.3. Anti-inflammatory Properties

As a non-steroidal anti-inflammatory drug (NSAID), salicylic acid exhibits significant anti-inflammatory effects. It modulates the enzymatic activity of cyclooxygenase enzymes (COX-1 and COX-2), which are responsible for converting arachidonic acid into pro-inflammatory prostaglandins.[10] By inhibiting prostaglandin synthesis, it reduces the erythema (redness) and edema (swelling) associated with inflammatory skin conditions like acne.[6] Beyond COX inhibition, salicylic acid also influences intracellular signaling pathways by inhibiting transcription factors such as NF-κB, which play a central role in orchestrating the genetic expression of inflammatory mediators.[30]

3.1.4. Antimicrobial and Sebum-Regulating Effects

Salicylic acid possesses intrinsic bacteriostatic and fungicidal properties, allowing it to neutralize microorganisms within pores and on the skin surface, including acne-associated bacteria.[1] Furthermore, it has been shown to reduce sebum secretion, which further contributes to its therapeutic effect in acne by reducing the oily substrate in which bacteria can thrive.[4]

3.2. Pharmacodynamics

The primary pharmacodynamic effect of topical salicylic acid is visible exfoliation and desquamation of the skin.[3] This action leads to the clinical softening and loosening of dry, scaly, or thickened skin, resulting in the improvement of hyperkeratotic disorders (e.g., psoriasis, ichthyosis), the removal of verrucae and calluses, and the resolution of comedones in acne.[1] Its anti-inflammatory action manifests as a visible reduction in redness and swelling.[6]

If significant percutaneous absorption occurs, salicylic acid can exert systemic pharmacodynamic effects identical to those of oral salicylates. These include analgesia, antipyresis, and, at toxic concentrations, a complex acid-base disturbance characterized by initial stimulation of the respiratory center, leading to respiratory alkalosis, which is often followed by a severe metabolic acidosis.[1]

3.3. Pharmacokinetics: Absorption, Distribution, Metabolism, and Excretion (ADME)

The pharmacokinetic profile of topical salicylic acid presents a unique clinical challenge. Under normal use, it behaves as a locally acting agent. However, under specific conditions, it can be absorbed systemically in sufficient quantities to produce significant systemic effects and toxicity.

3.3.1. Absorption

Salicylic acid is absorbed percutaneously, but the extent of absorption is highly variable and influenced by several critical factors.[2] Absorption through intact, healthy skin is minimal. However, this changes dramatically when the skin barrier is compromised; absorption can increase up to 150-fold through inflamed or tape-stripped skin.[35] Other factors that significantly enhance absorption include the use of high concentrations, application to large body surface areas, and the use of occlusive dressings.[1] In a clinical study involving patients with psoriasis, over 60% of a 6% salicylic acid gel was absorbed when applied over a large area under occlusion.[31] Following topical application with occlusion, peak serum salicylate levels are typically reached within 5 to 6 hours.[2]

3.3.2. Distribution

Once absorbed into the systemic circulation, salicylic acid is distributed throughout the extracellular space, with a volume of distribution of approximately 0.17 L/kg.[2] It is extensively bound (50–90%) to plasma proteins, primarily albumin.[2] This high degree of protein binding is a key factor in its potential for drug-drug interactions, as it can be displaced by or can displace other highly protein-bound drugs from albumin, thereby increasing their free, pharmacologically active concentrations.[31]

3.3.3. Metabolism

Absorbed salicylic acid is extensively metabolized, predominantly in the liver.[10] The two main metabolic pathways are conjugation with glycine to form salicyluric acid and conjugation with glucuronic acid to form salicylate glucuronides. Following topical administration, the major urinary metabolites are salicyluric acid (approximately 52%) and salicylate glucuronides (approximately 42%).[2]

3.3.4. Excretion

Salicylic acid and its metabolites are eliminated from the body primarily via renal excretion.[38] A small fraction, around 6–10%, is excreted as unchanged free salicylic acid.[2] The renal clearance of salicylic acid is highly sensitive to urinary pH. Alkalinization of the urine increases the ionization of the salicylic acid molecule, which traps it within the renal tubules and prevents its reabsorption, thereby dramatically increasing its rate of excretion.[15] This principle is a cornerstone of the medical management of salicylate poisoning. Under normal conditions, approximately 95% of a single absorbed dose is excreted in the urine within 24 hours.[2]

The pharmacokinetic profile reveals a potential for a dangerous feedback loop in cases of overdose. As systemic salicylate levels rise, they can induce a metabolic acidosis.[15] This acidemia lowers urinary pH, which in turn reduces the renal clearance of salicylic acid, causing its levels to rise further and exacerbating the acidosis. This vicious cycle explains the potential for rapid clinical deterioration in severe salicylate poisoning originating from topical use.

Section 4: Clinical Applications and Therapeutic Guidelines

The clinical utility of salicylic acid is exceptionally broad, driven by its multiple mechanisms of action. Its application is governed by a fundamental principle: concentration dictates function. At lower concentrations, it acts as a desmolytic and comedolytic agent, while at higher concentrations, it becomes a potent keratolytic and tissue-destructive agent.

4.1. Management of Hyperkeratotic and Scaly Disorders

• Psoriasis and Seborrheic Dermatitis: In these conditions, salicylic acid is used to soften, lift, and remove the adherent scales and plaques characteristic of the diseases.[1] It is frequently employed as an adjunctive therapy, where its keratolytic action serves as a crucial penetration enhancer. By removing the hyperkeratotic barrier, it allows other topical medications, such as corticosteroids or antifungals, to reach their target sites in the epidermis more effectively.[2]
• Ichthyoses: Salicylic acid is used to manage the excessive dryness and scaling associated with this group of inherited skin disorders.[1]
• Dandruff: Its ability to regulate epidermal cell turnover makes it a common and effective ingredient in medicated shampoos for controlling scalp flaking.[1]
• Calluses, Corns, and Warts (Verrucae): High concentrations of salicylic acid are a mainstay for the removal of these common hyperkeratotic lesions. Its potent keratolytic and destructive effects progressively break down the thickened tissue, leading to its eventual removal.[1]

4.2. Management of Acne Vulgaris

Salicylic acid is a first-line OTC agent for clearing and preventing acne lesions.[6] Its efficacy stems from a combination of effects:

• Comedolytic Action: It penetrates into follicles to exfoliate and unplug pores, treating existing comedones and preventing the formation of new ones.[1]
• Anti-inflammatory Action: It reduces the redness and swelling associated with inflammatory papules and pustules.[6]
• Bacteriostatic and Sebum-Regulating Effects: It helps to control acne-associated bacteria and reduce excess oil on the skin.[1]

4.3. Other Dermatological Indications

• Ringworm (Tinea): Its fungicidal properties make it a useful component in topical antifungal preparations, such as the classic Whitfield's Ointment.[1]
• Keratosis Pilaris, Lichen Simplex, and Acanthosis Nigricans: Its exfoliating properties are utilized to improve the texture and appearance of skin affected by these conditions.[3]
• Chemical Peeling: In professionally applied concentrations of 20–30%, salicylic acid functions as a superficial chemical peel to treat conditions like photodamage, melasma, freckles, and lentigines.[1]

4.4. Combination Therapies

To achieve synergistic effects, salicylic acid is frequently formulated with other active ingredients:

• With Sulfur and/or Coal Tar: For enhanced efficacy in psoriasis and seborrheic dermatitis.[10]
• With Urea: To provide enhanced hydration and keratolysis, particularly for callused skin on the feet.[11]
• With Benzoyl Peroxide: For comprehensive acne treatment, although the combination increases the potential for skin irritation.[3]
• With Topical Corticosteroids: As seen in products like Diprosalic®, the keratolytic effect of salicylic acid significantly enhances the penetration and efficacy of the steroid in treating inflammatory and hyperkeratotic dermatoses.[40]

4.5. Contraindicated/Inappropriate Uses

Topical salicylic acid should not be used to treat certain lesions due to the risk of severe irritation or unpredictable effects. These include genital warts, warts on the face, warts with hair growing from them, and warts located inside the nose or mouth. It is also contraindicated for use on moles or birthmarks.[5]

Section 5: Formulations, Concentrations, and Dosage Regimens

This section provides practical, actionable guidance on the clinical use of salicylic acid. The choice of formulation is as critical as the concentration, as the vehicle impacts drug delivery, patient adherence, and the potential for local irritation. A shampoo is designed for the scalp, while an occlusive plaster provides targeted delivery for a wart. The dosing instructions often include guidance for titration, such as starting with once-daily application and reducing frequency if excessive dryness occurs.[3] This implicitly positions salicylic acid as a drug with a narrow therapeutic window for local tolerability, where the optimal dose is often the highest one that can be tolerated without undue side effects. This is a crucial point for patient education to ensure adherence.

5.1. Overview of Available Formulations

Salicylic acid is available in a vast array of topical dosage forms, including creams, lotions, gels, ointments, shampoos, soaps, medicated pads or wipes, plasters, and topical solutions.[5] These are available both over-the-counter (OTC) and by prescription, with higher-strength formulations typically requiring a prescription.[5]

5.2. Concentration-Specific Dosing by Indication

The appropriate concentration and dosing regimen for salicylic acid are highly dependent on the condition being treated. Table 2 provides a comprehensive summary of these guidelines.

Table 2: Formulations and Dosing Guidelines by Indication

Indication	Formulation	Typical Concentration Range	Recommended Dosage and Administration Guidelines	Source(s)
Acne Vulgaris	Gel, Lotion, Cream, Pads, Solution, Soap	0.5% – 5%	Apply a thin layer to the affected area 1 to 3 times daily. To minimize irritation, start with 1 application daily, then gradually increase as tolerated. If bothersome dryness or peeling occurs, reduce application to once daily or every other day.	3
Psoriasis & Seborrheic Dermatitis	Cream, Ointment, Gel, Lotion	3% – 10%	Apply to affected areas 1 to 4 times daily as needed. For some products, pre-hydrating the skin for 5 minutes enhances effect.	3
Dandruff & Scalp Dermatitis	Shampoo, Lotion	1.8% – 3%	Shampoo: Use at least twice weekly. Lather, massage into scalp, leave on for several minutes, then rinse thoroughly. Lotion: Apply to scalp 1 to 2 times daily.	3
Common & Plantar Warts	Liquid, Gel, Plaster, Patch	5% – 40% (up to 60% in some ointments)	Liquid/Gel (5-27%): Apply 1 to 2 times daily. Plaster/Patch (up to 40%): Apply every 48 hours. Pre-soak the area in warm water for 5 minutes and debride the surface before application. Continue treatment for up to 12 weeks.	3
Corns & Calluses	Liquid, Cream, Plaster	12% – 60%	Liquid (12-27%): Apply 1 to 2 times daily. Plaster (up to 40%): Apply every 48 hours. Continue treatment for up to 14 days. Pre-soaking is recommended.	3
Chemical Peeling (Professional Use)	Solution	20% – 30%	Applied by a healthcare professional for 2-4 minutes depending on clinical response and skin tolerance.	1

Section 6: Safety Profile, Toxicology, and Risk Mitigation

The safety profile of topical salicylic acid is defined by a crucial distinction between local and systemic exposure. When used appropriately on limited areas of intact skin, its risks are generally confined to manageable local irritation. However, when the skin barrier is compromised or application is excessive, it can be absorbed into the systemic circulation. At this point, its safety profile transforms into that of oral aspirin, carrying risks of systemic toxicity (salicylism), metabolic derangements, and, in children, Reye's syndrome. Effective risk mitigation, therefore, is centered on controlling percutaneous absorption.

6.1. Local Adverse Effects

The most frequently reported side effects are local and related to its primary mechanism of action. These include skin irritation, stinging or burning sensations, erythema, dryness, and peeling, which are particularly common at the start of therapy.[1] In individuals with darker skin phototypes (Fitzpatrick IV-VI), the use of high-concentration peels (20–30%) carries a risk of post-inflammatory hyperpigmentation, making the concurrent use of broad-spectrum sun protection essential.[1] Salicylic acid can also increase the skin's sensitivity to ultraviolet radiation, necessitating diligent sun avoidance and protection.[1] While rare, severe hypersensitivity reactions can occur, presenting as urticaria (hives), pruritus (itching), angioedema, and, in severe cases, anaphylaxis with throat tightness and difficulty breathing.[3]

6.2. Systemic Toxicity (Salicylism)

Systemic toxicity from absorbed salicylate is the most serious potential risk, though it is rare with correct topical use.[1] The clinical presentation of salicylism includes a constellation of symptoms: nausea, vomiting, diarrhea, dizziness, tinnitus (ringing in the ears), hearing loss, headache, confusion, lethargy, and hyperpnea (abnormally deep or rapid breathing).[6] Severe overdose can lead to a characteristic dual acid-base disturbance, beginning with a respiratory alkalosis from direct stimulation of the medullary respiratory center, which is often followed by a severe high anion gap metabolic acidosis.[1] Acute systemic overdose carries a significant morbidity rate of 16% and a mortality rate of 1%.[1]

The risk of developing salicylism is significantly increased by several factors that enhance percutaneous absorption:

• Application to large body surface areas.[1]
• Use of high concentrations or occlusive dressings.[31]
• Application to broken, inflamed, or highly vascular skin.[6]
• Prolonged, continuous use.[31]
• Impaired drug clearance in patients with renal or hepatic disease.[31]
• Use in pediatric patients, who have a higher body surface area to weight ratio.[1]

6.3. Contraindications and Precautions

• Absolute Contraindications: A known history of hypersensitivity to salicylic acid or other salicylates, including aspirin, is an absolute contraindication.[6]
• Precautions and Relative Contraindications: Caution is strongly advised in patients with diabetes mellitus, peripheral vascular disease, or other conditions associated with impaired circulation. In these individuals, the intended keratolytic action of salicylic acid can easily create a chemical wound or ulceration that may not heal properly due to compromised skin integrity and reduced healing capacity.[5] Furthermore, diabetic neuropathy can mask the early warning signs of pain and irritation, potentially allowing for more extensive tissue damage before the product is discontinued. For this reason, use in these populations should be avoided, especially on the hands and feet.[5] The medication should not be applied to skin that is already broken, red, swollen, irritated, or infected.[6] Contact with eyes, mucous membranes, moles, birthmarks, and hairy warts must be avoided.[5]

6.4. Use in Special Populations

• Pediatrics: The use of salicylic acid is generally not recommended in children under the age of two.[1] A critical and absolute contraindication is its use in children and teenagers who have or are recovering from influenza or varicella (chickenpox). In this setting, systemic absorption of salicylate is associated with Reye's syndrome, a rare but often fatal condition characterized by acute encephalopathy and fatty degenerative liver failure.[5]
• Pregnancy: Salicylic acid is classified as FDA Pregnancy Category C. Teratogenic effects have been observed in animal studies following high oral doses. Therefore, it should be used during pregnancy only if the potential clinical benefit is deemed to outweigh the potential risk to the fetus.[31]
• Breastfeeding: There is a lack of adequate studies to determine infant risk when the medication is used by a breastfeeding mother. The decision to use it should involve weighing the potential maternal benefits against the potential risks to the infant.[5]

Section 7: Clinically Significant Interactions

The interaction profile of salicylic acid is dual-natured, operating on both a local and a systemic level. Clinicians must assess risk on both fronts. Local interactions are largely predictable and involve additive pharmacodynamic effects on the skin. Systemic interactions are pharmacokinetic in nature and become clinically relevant only when significant percutaneous absorption occurs.

7.1. Drug-Drug Interactions

• Topical Interactions: Co-administration of salicylic acid with other topical peeling agents (e.g., benzoyl peroxide, retinoids like tretinoin, resorcinol, sulfur), abrasive soaps, or alcohol-containing cleansers can result in cumulative irritation, leading to excessive skin dryness and inflammation.[3] Furthermore, the UV-filtering properties of salicylic acid can decrease the efficacy of UVB phototherapy used for psoriasis.[2]
• Systemic Interactions (following significant absorption):
• Protein Binding Displacement: Due to its high affinity for plasma albumin, absorbed salicylic acid can displace other highly protein-bound drugs, increasing their free (active) concentrations and risk of toxicity. Clinically significant interactions have been reported with methotrexate (increasing its toxicity) and sulfonylureas (potentiating hypoglycemia).[31]
• Anticoagulants: Salicylic acid can enhance the effects of oral anticoagulants like warfarin and interfere with platelet function, increasing bleeding risk, especially in patients also receiving heparin.[15]
• Alteration of Salicylate Levels: Systemic corticosteroid use can decrease plasma salicylate levels; tapering the steroid dose may unmask this effect and lead to salicylism. Conversely, acidifying agents can increase salicylate levels, while alkalinizing agents (which raise urinary pH) decrease levels by promoting renal excretion.[31]

7.2. Drug-Disease Interactions

• Diabetes Mellitus / Peripheral Vascular Disease: As detailed previously, patients with these conditions are at a heightened risk of developing non-healing skin ulcerations from salicylic acid's keratolytic effects.[5]
• Renal and Hepatic Impairment: Patients with compromised kidney or liver function have a reduced capacity to metabolize and excrete absorbed salicylate, placing them at a much higher risk of developing systemic toxicity, even with conventional topical use.[2]
• Influenza or Varicella in Children/Teenagers: This combination is contraindicated due to the established risk of Reye's Syndrome.[6]

7.3. Drug-Laboratory Test Interactions

Systemically absorbed salicylate can interfere with several common laboratory tests, potentially leading to misinterpretation of results. These interferences include:

• Thyroid Function: Decreased protein-bound iodine (PBI) and increased T3​ uptake.[31]
• Urinary Glucose: False-negative results with glucose oxidase methods and false-positive results with copper reduction tests (e.g., Clinitest) at high doses.[31]
• Other Tests: Can cause falsely reduced values for urinary 5-hydroxyindoleacetic acid (5-HIAA), 17-hydroxycorticosteroids, and vanillylmandelic acid (VMA). It may also increase or decrease uric acid levels depending on the dose.[31] The potential for these interactions underscores the importance of obtaining a complete medication history, including all OTC topical products, when investigating anomalous laboratory findings.

Conclusion and Expert Insights

Salicylic acid stands as a remarkably versatile and enduring agent in the dermatological armamentarium. Its journey from an ancient herbal remedy in willow bark to a purified, synthetically produced molecule illustrates a foundational narrative in pharmacology. The core of its therapeutic profile lies in a critical, concentration-dependent duality of action: at low concentrations, it functions as a nuanced modulator of keratinization and a comedolytic agent, while at high concentrations, it transforms into a potent keratolytic and tissue-ablative therapy.

This dual nature is both its greatest strength and its primary liability. The key to safely and effectively harnessing its power lies in the judicious selection of the correct concentration and formulation to match the specific pathology being treated. A 2% lotion for facial acne operates under a completely different therapeutic paradigm than a 40% plaster for a plantar wart. The clinician's role is to navigate this spectrum with precision.

Ultimately, the safe use of salicylic acid hinges on respecting the boundary between local and systemic effects. The paramount importance of patient education cannot be overstated. Patients must understand the risks associated with application to large surface areas, inflamed skin, or under occlusion—conditions that can erase this boundary and convert a targeted topical therapy into a potentially hazardous systemic exposure. The long and rich history of salicylic acid serves as a constant reminder of its inherent biological power and the clinical respect it commands.

Works cited

1. Medical uses of salicylic acid - Wikipedia, accessed September 26, 2025, https://en.wikipedia.org/wiki/Medical_uses_of_salicylic_acid
2. What is the mechanism of action of salicylic acid in treating skin conditions? - Dr.Oracle AI, accessed September 26, 2025, https://www.droracle.ai/articles/312745/what-does-salicylic-acid-do
3. Salicylic Acid: Uses, Alternatives, FAQs & More - GoodRx, accessed September 26, 2025, https://www.goodrx.com/salicylic-acid/what-is
4. Salicylic acid as a peeling agent: a comprehensive review - PMC - PubMed Central, accessed September 26, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC4554394/
5. Salicylic acid (topical route) - Side effects & dosage - Mayo Clinic, accessed September 26, 2025, https://www.mayoclinic.org/drugs-supplements/salicylic-acid-topical-route/description/drg-20066030
6. Salicylic Acid Topical: MedlinePlus Drug Information, accessed September 26, 2025, https://medlineplus.gov/druginfo/meds/a607072.html
7. Salicylic acid - Search Results | DrugBank Online, accessed September 26, 2025, https://go.drugbank.com/unearth/q?query=LACTIC+ACID+AND+SALICYLIC+ACID&searcher=drugs
8. Salicylic acid CAS 69-72-7 | 100631, accessed September 26, 2025, https://www.merckmillipore.com/FR/en/product/Salicylic-acid,MDA_CHEM-100631
9. CAS No : 69-72-7 | Chemical Name : Salicylic Acid | Pharmaffiliates, accessed September 26, 2025, https://www.pharmaffiliates.com/en/69-72-7-salicylic-acid-papst013510.html
10. Salicylic acid: Uses, Interactions, Mechanism of Action | DrugBank Online, accessed September 26, 2025, https://go.drugbank.com/drugs/DB00936
11. Salicylic acid - brand name list from Drugs.com, accessed September 26, 2025, https://www.drugs.com/ingredient/salicylic-acid.html
12. Salicylic acid | CAS 69-72-7 | SCBT, accessed September 26, 2025, https://www.scbt.com/p/salicylic-acid-69-72-7
13. Salicylic acid = 99 , FG 69-72-7 - Sigma-Aldrich, accessed September 26, 2025, https://www.sigmaaldrich.com/US/en/product/aldrich/w398500
14. Salicylic acid - Wikipedia, accessed September 26, 2025, https://en.wikipedia.org/wiki/Salicylic_acid
15. Salicylic Acid (Aspirin) - StatPearls - NCBI Bookshelf, accessed September 26, 2025, https://www.ncbi.nlm.nih.gov/books/NBK519032/
16. Salicylic Acid | HOC6H4COOH | CID 338 - PubChem, accessed September 26, 2025, https://pubchem.ncbi.nlm.nih.gov/compound/Salicylic-Acid
17. What is the mechanism of Salicylic acid? - Patsnap Synapse, accessed September 26, 2025, https://synapse.patsnap.com/article/what-is-the-mechanism-of-salicylic-acid
18. Salicylic acid: properties and cosmetic applications - PCC Group Product Portal, accessed September 26, 2025, https://www.products.pcc.eu/en/blog/salicylic-acid-properties-and-cosmetic-applications/
19. Salicylic Acid structure – C 7 H 6 O 3 - BYJU'S, accessed September 26, 2025, https://byjus.com/chemistry/salicylic-acid/
20. Salicylic acid (PIM 642) - Inchem.org, accessed September 26, 2025, https://www.inchem.org/documents/pims/pharm/pim642.htm
21. Salicylic Acid | ACS Reagent Chemicals, accessed September 26, 2025, https://pubs.acs.org/doi/10.1021/acsreagents.4318
22. Salicylic acid | 69-72-7 - ChemicalBook, accessed September 26, 2025, https://www.chemicalbook.com/ChemicalProductProperty_EN_CB1680010.htm
23. ICSC 0563 - SALICYLIC ACID - Inchem.org, accessed September 26, 2025, https://www.inchem.org/documents/icsc/icsc/eics0563.htm
24. Aspirin: Turn-of-the-Century Miracle Drug | Science History Institute, accessed September 26, 2025, https://www.sciencehistory.org/stories/magazine/aspirin-turn-of-the-century-miracle-drug/
25. Historical perspective of aspirin: A journey from discovery to clinical practice Ancient and modern history, accessed September 26, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC8302889/
26. THE HISTORY OF ASPIRIN: THE DISCOVERIES THAT CHANGED CONTEMPORARY MEDICINE - The Pontifical Academy of Sciences, accessed September 26, 2025, https://www.pas.va/content/dam/casinapioiv/pas/pdf-volumi/acta/acta-18-pdf-papers/acta18-szczeklik.pdf
27. Origin Story of Aspirin - UTMB Health, The University of Texas Medical Branch, accessed September 26, 2025, https://www.utmb.edu/mdnews/podcast/episode/origin-story-of-aspirin
28. Aspirin | Circulation - AHA Journals, accessed September 26, 2025, https://www.ahajournals.org/doi/10.1161/circulationaha.110.963843
29. The Early Clinical History of Salicylates in Rheumatology and Pain - PubMed, accessed September 26, 2025, https://pubmed.ncbi.nlm.nih.gov/9586674/
30. What is the mechanism of action of salicylic acid in the body ..., accessed September 26, 2025, https://consensus.app/search/what-is-the-mechanism-of-action-of-salicylic-acid-/3uLO7mBtQ3a8obWOG5uJmQ/
31. Salicylic Acid: Package Insert / Prescribing Information - Drugs.com, accessed September 26, 2025, https://www.drugs.com/pro/salicylic-acid.html
32. Salicylic-acid - Mechanism, Indication, Contraindications, Dosing, Adverse Effect, Interaction, Hepatic Dose | Drug Index | Pediatric Oncall, accessed September 26, 2025, https://www.pediatriconcall.com/drugs/salicylic-acid/935
33. salicylic acid topical (Rx, OTC) - Medscape Reference, accessed September 26, 2025, https://reference.medscape.com/drug/compound-w-for-kids-salicylic-acid-topical-999359
34. medlineplus.gov, accessed September 26, 2025, https://medlineplus.gov/druginfo/meds/a607072.html#:~:text=Salicylic%20acid%20is%20in%20a,to%20allow%20pimples%20to%20shrink.
35. A review of toxicity from topical salicylic acid preparations - E-lactancia, accessed September 26, 2025, https://www.e-lactancia.org/media/papers/SalicilicoPK-jAmAcDerm2014.pdf
36. Salicylic Acid for Acne: Benefits, Dosages, and Side Effects - Healthline, accessed September 26, 2025, https://www.healthline.com/health/skin/salicylic-acid-for-acne
37. Salicylic Acid | Drug Lookup | Pediatric Care Online, accessed September 26, 2025, https://publications.aap.org/pediatriccare/drug-monograph/18/5367/Salicylic-Acid
38. Aspirin - Wikipedia, accessed September 26, 2025, https://en.wikipedia.org/wiki/Aspirin
39. Drug Interactions Involving Aspirin (Acetylsalicylic Acid) and Salicylic Acid - PubMed, accessed September 26, 2025, https://pubmed.ncbi.nlm.nih.gov/2573442/
40. Salicylic acid - DermNet, accessed September 26, 2025, https://dermnetnz.org/topics/salicylic-acid
41. Salicylic Acid for Psoriasis: Is It Right for You? - Healthline, accessed September 26, 2025, https://www.healthline.com/health/salicylic-acid-psoriasis
42. Salicylic Acid: Uses, Brands & Interactions - Cleveland Clinic, accessed September 26, 2025, https://my.clevelandclinic.org/health/drugs/20341-salicylic-acid-topical-gel-cream-lotion-solution
43. Salicylic acid wart removal: Effectiveness and how to use - Medical News Today, accessed September 26, 2025, https://www.medicalnewstoday.com/articles/324732
44. Salicylic Acid Monograph for Professionals - Drugs.com, accessed September 26, 2025, https://www.drugs.com/monograph/salicylic-acid.html
45. What is the prescribed dose of salicylic acid? - Dr.Oracle AI, accessed September 26, 2025, https://www.droracle.ai/articles/246115/what-is-the-prescripted-dose-of-salicylic-acid
46. Salicylic acid topical Uses, Side Effects & Warnings - Drugs.com, accessed September 26, 2025, https://www.drugs.com/mtm/salicylic-acid-topical.html
47. Salicylic Acid Topical: Side Effects, Uses, Dosage, Interactions, Warnings - RxList, accessed September 26, 2025, https://www.rxlist.com/salicylic_acid_topical/generic-drug.htm